PAVmed (PAVM) Net Income towards Common Stockholders (2016 - 2026)
PAVmed (PAVM) posted quarterly Net Income towards Common Stockholders of -$1.9 million for Q4 2025, down 238.04% year-over-year from $1.3 million in Q4 2024, and up 70.64% quarter-over-quarter from -$6.3 million in Q3 2025.
PAVmed (PAVM) Net Income towards Common Stockholders (2016 - 2026) Analysis & Trends
PAVmed's Net Income towards Common Stockholders history runs 10 years deep, the most recent figure standing at -$1.9 million for Q4 2025.
- In Q4 2025, Net Income towards Common Stockholders fell 238.04% year-over-year to -$1.9 million; the TTM figure through Dec 2025 stood at -$3.8 million (up 88.26% YoY), while the FY2025 annual figure was -$3.8 million, down 111.89% from the prior year.
- Net Income towards Common Stockholders for Q4 2025 stood at -$1.9 million, up from -$6.3 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $17.7 million in Q1 2025, with the low at -$26.2 million in Q3 2022.
- The 5-year median for Net Income towards Common Stockholders is -$14.6 million (2023), against an average of -$12.8 million.
- Peak annual rise in Net Income towards Common Stockholders reached 177.65% in 2025, while the deepest fall reached 238.04% in 2025.
- PAVmed's Net Income towards Common Stockholders stood at -$17.3 million in 2021, then decreased by 18.79% to -$20.5 million in 2022, then rose by 22.54% to -$15.9 million in 2023, then soared by 108.46% to $1.3 million in 2024, then slumped by 238.04% to -$1.9 million in 2025.
- Business Quant data shows PAVM's Net Income towards Common Stockholders at -$1.9 million in Q4 2025, -$6.3 million in Q3 2025, and -$13.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | PAVmed | 32.48 Mn | 28.69 Mn | -89,000.00 | -5.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.48 Mn |
| Dec 31, 2025 | -1.86 Mn |
| Sep 30, 2025 | -6.33 Mn |
| Jun 30, 2025 | -13.31 Mn |
| Mar 31, 2025 | 17.70 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Jun 30, 2024 | -10.91 Mn |
| Mar 31, 2024 | -22.79 Mn |
| Dec 31, 2023 | -15.91 Mn |
| Sep 30, 2023 | -17.75 Mn |
| Jun 30, 2023 | -14.61 Mn |
| Mar 31, 2023 | -18.01 Mn |
| Dec 31, 2022 | -20.53 Mn |
| Sep 30, 2022 | -26.20 Mn |
| Jun 30, 2022 | -25.60 Mn |
| Mar 31, 2022 | -16.94 Mn |
| Dec 31, 2021 | -17.29 Mn |
| Sep 30, 2021 | -12.29 Mn |
| Jun 30, 2021 | -11.55 Mn |
| Mar 31, 2021 | -9.51 Mn |